Next Article in Journal
Overexpression of PRL7D1 in Leydig Cells Causes Male Reproductive Dysfunction in Mice
Next Article in Special Issue
miR-30-5p Regulates Muscle Differentiation and Alternative Splicing of Muscle-Related Genes by Targeting MBNL
Previous Article in Journal
Enrichment of Secondary Wastewater Sludge for Production of Hydrogen from Crude Glycerol and Comparative Evaluation of Mono-, Co- and Mixed-Culture Systems
Previous Article in Special Issue
Circulating MicroRNAs as Biomarkers for Sepsis
Open AccessReview

miRNAs Regulation and Its Role as Biomarkers in Endometriosis

1
Unit of Hemostasia, Thrombosis, Atherosclerosis and Vascular Biology, Health Research Institute La Fe, Valencia 46026, Spain
2
Arrays Unit, Health Research Institute La Fe, Valencia 46026, Spain
3
Maternal Child Area, General Hospital, Valencia 46014, Spain
4
Epigomics Unit, Health Research Institute La Fe, Valencia 46026, Spain
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
These authors contributed equally to this work.
Academic Editors: Nalini Santanam and William Chi-shing Cho
Int. J. Mol. Sci. 2016, 17(1), 93; https://doi.org/10.3390/ijms17010093
Received: 21 December 2015 / Revised: 5 January 2016 / Accepted: 8 January 2016 / Published: 13 January 2016
(This article belongs to the Special Issue MicroRNA in Various Disease States as Biomarkers)
MicroRNAs (miRNAs) are small non-coding RNAs (18–22 nt) that function as modulators of gene expression. Since their discovery in 1993 in C. elegans, our knowledge about their biogenesis, function, and mechanism of action has increased enormously, especially in recent years, with the development of deep-sequencing technologies. New biogenesis pathways and sources of miRNAs are changing our concept about these molecules. The study of the miRNA contribution to pathological states is a field of great interest in research. Different groups have reported the implication of miRNAs in pathologies such as cancer, diabetes, cardiovascular, and gynecological diseases. It is also well-known that miRNAs are present in biofluids (plasma, serum, urine, semen, and menstrual blood) and have been proposed as ideal candidates as disease biomarkers. The goal of this review is to highlight the current knowledge in the field of miRNAs with a special emphasis to their role in endometriosis and the newest investigations addressing the use of miRNAs as biomarkers for this gynecological disease. View Full-Text
Keywords: non-coding RNA; microRNA; biomarker; endometriosis non-coding RNA; microRNA; biomarker; endometriosis
Show Figures

Figure 1

MDPI and ACS Style

Marí-Alexandre, J.; Sánchez-Izquierdo, D.; Gilabert-Estellés, J.; Barceló-Molina, M.; Braza-Boïls, A.; Sandoval, J. miRNAs Regulation and Its Role as Biomarkers in Endometriosis. Int. J. Mol. Sci. 2016, 17, 93.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop